NO892366L - Heparinderivater og fremgangsmaate til fremstilling derav. - Google Patents

Heparinderivater og fremgangsmaate til fremstilling derav.

Info

Publication number
NO892366L
NO892366L NO89892366A NO892366A NO892366L NO 892366 L NO892366 L NO 892366L NO 89892366 A NO89892366 A NO 89892366A NO 892366 A NO892366 A NO 892366A NO 892366 L NO892366 L NO 892366L
Authority
NO
Norway
Prior art keywords
heparins
heparin
derivatives
hemorrhagic
activity
Prior art date
Application number
NO89892366A
Other languages
English (en)
Other versions
NO174259C (no
NO892366D0 (no
NO174259B (no
Inventor
Silvano Piani
Gianfranco Tamagnone
Paul Roberto Alpino
Maria Rita Milani
Marinella Fantuz
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of NO892366D0 publication Critical patent/NO892366D0/no
Publication of NO892366L publication Critical patent/NO892366L/no
Publication of NO174259B publication Critical patent/NO174259B/no
Publication of NO174259C publication Critical patent/NO174259C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
NO892366A 1988-06-10 1989-06-09 Fremgangsmåte til fremstilling av heparinderivater NO174259C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8803504A IT1234508B (it) 1988-06-10 1988-06-10 Derivati eparinici e procedimento per la loro preparazione

Publications (4)

Publication Number Publication Date
NO892366D0 NO892366D0 (no) 1989-06-09
NO892366L true NO892366L (no) 1989-12-11
NO174259B NO174259B (no) 1993-12-27
NO174259C NO174259C (no) 1994-04-06

Family

ID=11108618

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892366A NO174259C (no) 1988-06-10 1989-06-09 Fremgangsmåte til fremstilling av heparinderivater

Country Status (18)

Country Link
US (1) US5010063A (no)
EP (1) EP0347588B1 (no)
JP (1) JPH0739442B2 (no)
KR (1) KR960015110B1 (no)
AT (1) ATE109164T1 (no)
CA (1) CA1309402C (no)
DE (2) DE347588T1 (no)
DK (1) DK173818B1 (no)
ES (1) ES2012748T3 (no)
FI (1) FI94534C (no)
GR (1) GR900300018T1 (no)
IE (1) IE64830B1 (no)
IL (1) IL90411A (no)
IT (1) IT1234508B (no)
NO (1) NO174259C (no)
NZ (1) NZ229212A (no)
PT (1) PT90817B (no)
ZA (1) ZA893882B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US5232040A (en) * 1990-07-12 1993-08-03 Lanxide Technology Company, Lp Method for reducing metal content of self-supporting composite bodies and articles formed thereby
IT1243987B (it) * 1990-10-29 1994-06-28 Derivati Organici Lab Procedimento per la preparazione di epossi-eparidi prodotti ottenuti ecomposizioni farmaceutiche che li contengono
IT1254216B (it) * 1992-02-25 1995-09-14 Opocrin Spa Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1260137B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
IT1260136B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
US6750207B1 (en) 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
US5861382A (en) * 1992-05-01 1999-01-19 Yeda Research And Development Co. Ltd. Methods for regulation of active TNF-α
US5296471A (en) * 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
IT1264102B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonico sostituito con radicali
IT1264101B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2
US20020055710A1 (en) * 1998-04-30 2002-05-09 Ronald J. Tuch Medical device for delivering a therapeutic agent and method of preparation
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
WO1997016556A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
JP4498471B2 (ja) * 1996-11-27 2010-07-07 アヴェンティス ファーマシューティカルズ インコーポレイテッド 抗―Ｘａ活性を有する化合物及び血小板凝集拮抗剤化合物を含有する製薬組成物
US6106454A (en) * 1997-06-17 2000-08-22 Medtronic, Inc. Medical device for delivering localized radiation
US6203536B1 (en) 1997-06-17 2001-03-20 Medtronic, Inc. Medical device for delivering a therapeutic substance and method therefor
US6013099A (en) 1998-04-29 2000-01-11 Medtronic, Inc. Medical device for delivering a water-insoluble therapeutic salt or substance
EP1109919A2 (en) * 1998-08-27 2001-06-27 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
WO2000065521A2 (en) * 1999-04-23 2000-11-02 Massachusetts Institute Of Technology System and method for polymer notation
MXPA02000142A (es) * 1999-06-30 2003-07-21 Hamilton Civic Hospitals Res Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo.
ES2527853T3 (es) * 2000-03-08 2015-01-30 Massachusetts Institute Of Technology Heparinasa III y sus usos
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
WO2002020091A2 (en) * 2000-09-08 2002-03-14 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
WO2002023190A2 (en) 2000-09-12 2002-03-21 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
US7709461B2 (en) * 2000-10-18 2010-05-04 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US7285536B2 (en) * 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
ITMI20031679A1 (it) * 2003-08-29 2005-02-28 Opocrin Spa Processo per la produzione di eparine a basso peso
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US7608246B2 (en) * 2005-09-02 2009-10-27 The Brigham And Women's Hospital, Inc. Apolipoprotein E as an adjuvant for lipid antigens
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
US8435795B2 (en) * 2010-01-19 2013-05-07 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
JPWO2012036152A1 (ja) * 2010-09-14 2014-02-03 国立大学法人 宮崎大学 高純度ヘパリンおよびその製造方法
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
RU2639574C2 (ru) * 2016-05-23 2017-12-21 Алексей Георгиевич Александров Способ получения низкомолекулярного гепарина
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065140A (en) * 1958-07-05 1962-11-20 Roussel Uclaf Heparin derivatives and methods of preparing same
US3016331A (en) * 1960-01-28 1962-01-09 Ormonoterapia Richter Spa Purification of heparin
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
ES2003197A6 (es) * 1987-01-05 1988-10-16 Rovi Lab Farmaceut Sa Procedimiento de despolimerizacion de la heparina para la obtencion de una heparina de bajo peso molecular dotada de actividad antitrombotica
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione

Also Published As

Publication number Publication date
KR910000771A (ko) 1991-01-30
NZ229212A (en) 1991-02-26
DK285089D0 (da) 1989-06-09
DE68917040T2 (de) 1995-01-12
NO174259C (no) 1994-04-06
DE68917040D1 (de) 1994-09-01
ATE109164T1 (de) 1994-08-15
NO892366D0 (no) 1989-06-09
EP0347588B1 (en) 1994-07-27
ES2012748T3 (es) 1994-10-16
JPH0739442B2 (ja) 1995-05-01
FI94534C (fi) 1995-09-25
US5010063A (en) 1991-04-23
IL90411A (en) 1993-05-13
KR960015110B1 (ko) 1996-10-28
FI892850A (fi) 1989-12-11
DK173818B1 (da) 2001-11-19
IE64830B1 (en) 1995-09-06
DK285089A (da) 1989-12-11
ES2012748A4 (es) 1990-04-16
GR900300018T1 (en) 1991-06-07
IT1234508B (it) 1992-05-19
EP0347588A1 (en) 1989-12-27
IE891762L (en) 1989-12-10
IL90411A0 (en) 1990-01-18
CA1309402C (en) 1992-10-27
JPH0264102A (ja) 1990-03-05
IT8803504A0 (it) 1988-06-10
DE347588T1 (de) 1990-05-23
ZA893882B (en) 1990-02-28
NO174259B (no) 1993-12-27
PT90817B (pt) 1994-11-30
AU611028B2 (en) 1991-05-30
FI94534B (fi) 1995-06-15
AU3512889A (en) 1989-12-14
PT90817A (pt) 1989-12-29
FI892850A0 (fi) 1989-06-09

Similar Documents

Publication Publication Date Title
NO892366L (no) Heparinderivater og fremgangsmaate til fremstilling derav.
NO900392D0 (no) Heparinderivater og fremgangsmaate til fremstilling derav.
GEP20022656B (en) 2-(Purin-9-YL)-Tetrahydrofuran-3,4-Diol Derivatives
HU9200204D0 (en) Process for the production of benzyloxi-phenyl derivatives and medical preparations containing them
IN163242B (no)
ATE156190T1 (de) Familie von auf xanthan basierenden polysaccharidpolymeren, welche nichtacetylierten und/oder nichtpyruvylierten gum beeinhalten
AU533581B2 (en) Esters of 1,1,2-triphenylalkene derivatives
JPS5497691A (en) New mitomycin derivative
SU1078894A1 (ru) Способ получения гемосовместимых полимерных гидрогелей
GR880100225A (en) New derivatives of rivofurane acid

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2003